Literature DB >> 11908578

Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample.

Kevin P White1, Warren R Nielson, Manfred Harth, Truls Ostbye, Mark Speechley.   

Abstract

OBJECTIVE: To estimate the severity of depression, anxiety, and other symptoms of psychological distress in a representative general population sample of fibromyalgia (FM) cases (FC) compared to pain controls (PC), and to identify strong correlates of depression and anxiety.
METHODS: We compared the severity of depression, anxiety, and other symptoms of psychological distress between 2 representative community samples: (1) 74 confirmed FC, and (2) 48 adults with chronic widespread pain (PC) who did not meet the 1990 ACR criteria for FM. Psychological distress was measured using the Centre for Epidemiological Studies Depression (CES-D) Scale, the State-Trait Anxiety Inventory (STAI), and other measures of psychological distress from the literature. Using cutoff scores for CES-D and trait anxiety, we compared demographic and clinical characteristics in those above and below each cutoff score. Simple linear regression was performed to identify factors strongly and independently correlated with depression and trait anxiety.
RESULTS: Compared to PC, FC were more symptomatic on virtually all measures of psychological distress. Similarly, individuals who scored above cutoff scores for depression and anxiety had more physical symptoms and had poorer function than those below. Depression and trait anxiety were highly correlated (r = 0.86). In a simple regression model, the best predictors for both depression and trait anxiety were the total number of symptoms and a physical disability score.
CONCLUSION: Depression and anxiety are common and frequently severe even among community cases of FM.

Entities:  

Mesh:

Year:  2002        PMID: 11908578

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  45 in total

Review 1.  Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria.

Authors:  John McBeth; Matthew R Mulvey
Journal:  Nat Rev Rheumatol       Date:  2012-01-24       Impact factor: 20.543

Review 2.  Fibromyalgia: a rheumatologic diagnosis?

Authors:  Gerhard K M Endresen
Journal:  Rheumatol Int       Date:  2007-07-20       Impact factor: 2.631

3.  Advancing the screening of fibromyalgia in late-life depression: practical implications for psychiatric settings.

Authors:  John R Jochum; Amy E Begley; Mary Amanda Dew; Debra K Weiner; Jordan F Karp
Journal:  Int Psychogeriatr       Date:  2015-04-24       Impact factor: 3.878

4.  Correlates of perceived pain-related restrictions among women with fibromyalgia.

Authors:  Peter Przekop; Mark G Haviland; Kelly R Morton; Keiji Oda; Gary E Fraser
Journal:  Pain Med       Date:  2010-11       Impact factor: 3.750

5.  [AWMF guidelines for fibromyalgia syndrome].

Authors:  W Hardinghaus
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

6.  Understanding fibromyalgia and its related disorders.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

7.  [Definition, classification and diagnosis of fibromyalgia syndrome].

Authors:  W Eich; W Häuser; E Friedel; A Klement; M Herrmann; F Petzke; M Offenbächer; M Schiltenwolf; C Sommer; T Tölle; P Henningsen
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

8.  Is it necessary to strictly diagnose fibromyalgia syndrome in patients with chronic widespread pain?

Authors:  Arzu Yagiz On; Dilek Aykanat; Funda Calis Atamaz; Can Eyigor; Hayriye Kocanogullari; Fahrettin Oksel
Journal:  Clin Rheumatol       Date:  2015-05-26       Impact factor: 2.980

9.  The role of personality in patients with fibromyalgia.

Authors:  Andrew Seto; Xingyi Han; Lori Lyn Price; William F Harvey; Raveendhara R Bannuru; Chenchen Wang
Journal:  Clin Rheumatol       Date:  2018-10-01       Impact factor: 2.980

10.  New treatment options in the management of fibromyalgia: role of pregabalin.

Authors:  Grazyna Zareba
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.